APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fluoxetine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Fluoxetine Industry Growth and Trends Forecast to 2032

20 December 2025108 pages

Choose your research edition.

Industry ResearchFluoxetine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Fluoxetine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Fluoxetine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fluoxetine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Fluoxetine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Fluoxetine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Fluoxetine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Fluoxetine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fluoxetine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Fluoxetine include Teva, Sun Pharmaceutical, Suzhou YUSHI Pharmaceutical, Sandoz, Mylan, Changzhou Siyao Pharmaceutical, Wockhardt, Torrent Pharmaceuticals and Pharmaceutical Associates Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Fluoxetine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Fluoxetine market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Fluoxetine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Fluoxetine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Fluoxetine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Fluoxetine Market by Company

Teva

Sun Pharmaceutical

Suzhou YUSHI Pharmaceutical

Sandoz

Mylan

Changzhou Siyao Pharmaceutical

Wockhardt

Torrent Pharmaceuticals

Pharmaceutical Associates Inc.

Lannett Company

Dr.Reddy's Laboratories

Aurobindo Pharma

Alvogen

Alembic Pharmaceuticals

Fluoxetine Segment by Type

Capsules

Oral Solution

Tablets

Fluoxetine Segment by Application

Depression

Bulimia Nervosa

Obsessive–Compulsive Disorder

Panic Disorder

Others

Fluoxetine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fluoxetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fluoxetine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fluoxetine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fluoxetine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Fluoxetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Capsules Table 2. Major Company of Oral Solution Table 3. Major Company of Tablets Table 4. Global Fluoxetine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Fluoxetine Sales by Type (2021-2026) & (W Units) Table 6. Global Fluoxetine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Fluoxetine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Fluoxetine Sales Market Share in Value by Type (2021-2026) Table 9. Global Fluoxetine Price by Type (2021-2026) & (US$/Unit) Table 10. Global Fluoxetine Sales by Type (2027-2032) & (W Units) Table 11. Global Fluoxetine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Fluoxetine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Fluoxetine Sales Market Share in Value by Type (2027-2032) Table 14. Global Fluoxetine Price by Type (2027-2032) & (US$/Unit) Table 15. North America Fluoxetine Sales by Type (2021-2026) & (W Units) Table 16. North America Fluoxetine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Fluoxetine Sales by Type (2021-2026) & (W Units) Table 18. Europe Fluoxetine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Fluoxetine Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Fluoxetine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Fluoxetine Sales by Type (2021-2026) & (W Units) Table 22. Latin America Fluoxetine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Fluoxetine Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Fluoxetine Sales by Type (2021-2026) & (US$ Million) Table 25. Fluoxetine Industry Trends Table 26. Fluoxetine Industry Drivers Table 27. Fluoxetine Industry Opportunities and Challenges Table 28. Fluoxetine Industry Restraints Table 29. Global Fluoxetine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Fluoxetine Revenue Market Share by Company (2021-2026) Table 31. Global Fluoxetine Sales by Company (2021-2026) & (W Units) Table 32. Global Fluoxetine Sales Share by Company (2021-2026) Table 33. Global Fluoxetine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Fluoxetine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Fluoxetine Major Company Production Sites and Headquarters Table 36. Global Fluoxetine Company, Product Type & Application Table 37. Global Fluoxetine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Fluoxetine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Fluoxetine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Fluoxetine Sales by Region (2021-2026) & (W Units) Table 42. Global Fluoxetine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Fluoxetine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Fluoxetine Sales Market Share in Value by Region (2021-2026) Table 45. Global Fluoxetine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Fluoxetine Sales by Region (2027-2032) & (W Units) Table 47. Global Fluoxetine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Fluoxetine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Fluoxetine Sales Market Share in Value by Region (2027-2032) Table 50. Global Fluoxetine Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Fluoxetine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Fluoxetine Sales by Application (2021-2026) & (W Units) Table 53. Global Fluoxetine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Fluoxetine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Fluoxetine Sales Market Share in Value by Application (2021-2026) Table 56. Global Fluoxetine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Fluoxetine Sales by Application (2027-2032) & (W Units) Table 58. Global Fluoxetine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Fluoxetine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Fluoxetine Sales Market Share in Value by Application (2027-2032) Table 61. Global Fluoxetine Price by Application (2027-2032) & (US$/Unit) Table 62. North America Fluoxetine Sales by Application (2021-2026) & (W Units) Table 63. North America Fluoxetine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Fluoxetine Sales by Application (2021-2026) & (W Units) Table 65. Europe Fluoxetine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Fluoxetine Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Fluoxetine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Fluoxetine Sales by Application (2021-2026) & (W Units) Table 69. Latin America Fluoxetine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Fluoxetine Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Fluoxetine Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva Fluoxetine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Teva Fluoxetine Product Portfolio Table 76. Teva Recent Development Table 77. Sun Pharmaceutical Company Information Table 78. Sun Pharmaceutical Business Overview Table 79. Sun Pharmaceutical Fluoxetine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sun Pharmaceutical Fluoxetine Product Portfolio Table 81. Sun Pharmaceutical Recent Development Table 82. Suzhou YUSHI Pharmaceutical Company Information Table 83. Suzhou YUSHI Pharmaceutical Business Overview Table 84. Suzhou YUSHI Pharmaceutical Fluoxetine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Suzhou YUSHI Pharmaceutical Fluoxetine Product Portfolio Table 86. Suzhou YUSHI Pharmaceutical Recent Development Table 87. Sandoz Company Information Table 88. Sandoz Business Overview Table 89. Sandoz Fluoxetine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sandoz Fluoxetine Product Portfolio Table 91. Sandoz Recent Development Table 92. Mylan Company Information Table 93. Mylan Business Overview Table 94. Mylan Fluoxetine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Mylan Fluoxetine Product Portfolio Table 96. Mylan Recent Development Table 97. Changzhou Siyao Pharmaceutical Company Information Table 98. Changzhou Siyao Pharmaceutical Business Overview Table 99. Changzhou Siyao Pharmaceutical Fluoxetine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Changzhou Siyao Pharmaceutical Fluoxetine Product Portfolio Table 101. Changzhou Siyao Pharmaceutical Recent Development Table 102. Wockhardt Company Information Table 103. Wockhardt Business Overview Table 104. Wockhardt Fluoxetine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Wockhardt Fluoxetine Product Portfolio Table 106. Wockhardt Recent Development Table 107. Torrent Pharmaceuticals Company Information Table 108. Torrent Pharmaceuticals Business Overview Table 109. Torrent Pharmaceuticals Fluoxetine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Torrent Pharmaceuticals Fluoxetine Product Portfolio Table 111. Torrent Pharmaceuticals Recent Development Table 112. Pharmaceutical Associates Inc. Company Information Table 113. Pharmaceutical Associates Inc. Business Overview Table 114. Pharmaceutical Associates Inc. Fluoxetine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Pharmaceutical Associates Inc. Fluoxetine Product Portfolio Table 116. Pharmaceutical Associates Inc. Recent Development Table 117. Lannett Company Company Information Table 118. Lannett Company Business Overview Table 119. Lannett Company Fluoxetine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Lannett Company Fluoxetine Product Portfolio Table 121. Lannett Company Recent Development Table 122. Dr.Reddy's Laboratories Company Information Table 123. Dr.Reddy's Laboratories Business Overview Table 124. Dr.Reddy's Laboratories Fluoxetine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Dr.Reddy's Laboratories Fluoxetine Product Portfolio Table 126. Dr.Reddy's Laboratories Recent Development Table 127. Aurobindo Pharma Company Information Table 128. Aurobindo Pharma Business Overview Table 129. Aurobindo Pharma Fluoxetine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Aurobindo Pharma Fluoxetine Product Portfolio Table 131. Aurobindo Pharma Recent Development Table 132. Alvogen Company Information Table 133. Alvogen Business Overview Table 134. Alvogen Fluoxetine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Alvogen Fluoxetine Product Portfolio Table 136. Alvogen Recent Development Table 137. Alembic Pharmaceuticals Company Information Table 138. Alembic Pharmaceuticals Business Overview Table 139. Alembic Pharmaceuticals Fluoxetine Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Alembic Pharmaceuticals Fluoxetine Product Portfolio Table 141. Alembic Pharmaceuticals Recent Development Table 142. North America Fluoxetine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 143. North America Fluoxetine Sales by Country (2021-2026) & (W Units) Table 144. North America Fluoxetine Sales Market Share by Country (2021-2026) Table 145. North America Fluoxetine Sales Forecast by Country (2027-2032) & (W Units) Table 146. North America Fluoxetine Sales Market Share Forecast by Country (2027-2032) Table 147. North America Fluoxetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Fluoxetine Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Fluoxetine Market Share by Country (2021-2026) Table 150. North America Fluoxetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Fluoxetine Market Share Forecast by Country (2027-2032) Table 152. Europe Fluoxetine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 153. Europe Fluoxetine Sales by Country (2021-2026) & (W Units) Table 154. Europe Fluoxetine Sales Market Share by Country (2021-2026) Table 155. Europe Fluoxetine Sales Forecast by Country (2027-2032) & (W Units) Table 156. Europe Fluoxetine Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Fluoxetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Fluoxetine Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Fluoxetine Market Share by Country (2021-2026) Table 160. Europe Fluoxetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Fluoxetine Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Fluoxetine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Fluoxetine Sales by Country (2021-2026) & (W Units) Table 164. Asia-Pacific Fluoxetine Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Fluoxetine Sales Forecast by Country (2027-2032) & (W Units) Table 166. Asia-Pacific Fluoxetine Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Fluoxetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Fluoxetine Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Fluoxetine Market Share by Country (2021-2026) Table 170. Asia-Pacific Fluoxetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Fluoxetine Market Share Forecast by Country (2027-2032) Table 172. Latin America Fluoxetine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 173. Latin America Fluoxetine Sales by Country (2021-2026) & (W Units) Table 174. Latin America Fluoxetine Sales Market Share by Country (2021-2026) Table 175. Latin America Fluoxetine Sales Forecast by Country (2027-2032) & (W Units) Table 176. Latin America Fluoxetine Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Fluoxetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Fluoxetine Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Fluoxetine Market Share by Country (2021-2026) Table 180. Latin America Fluoxetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Fluoxetine Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Fluoxetine Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Fluoxetine Sales by Country (2021-2026) & (W Units) Table 184. Middle East and Africa Fluoxetine Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Fluoxetine Sales Forecast by Country (2027-2032) & (W Units) Table 186. Middle East and Africa Fluoxetine Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Fluoxetine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Fluoxetine Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Fluoxetine Market Share by Country (2021-2026) Table 190. Middle East and Africa Fluoxetine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Fluoxetine Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Fluoxetine Distributors List Table 195. Fluoxetine Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Fluoxetine Image Figure 2. Global Fluoxetine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fluoxetine Market Size (2021-2032) & (US$ Million) Figure 4. Global Fluoxetine Sales (2021-2032) & (W Units) Figure 5. Capsules Image Figure 6. Global Capsules Sales YoY Growth (2021-2032) & (W Units) Figure 7. Oral Solution Image Figure 8. Global Oral Solution Sales YoY Growth (2021-2032) & (W Units) Figure 9. Tablets Image Figure 10. Global Tablets Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Fluoxetine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Fluoxetine Market Share by Type 2025 VS 2032 Figure 13. North America Fluoxetine Sales Market Share in Volume by Type in 2025 Figure 14. North America Fluoxetine Sales Market Share in Value by Type in 2025 Figure 15. Europe Fluoxetine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Fluoxetine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Fluoxetine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Fluoxetine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Fluoxetine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Fluoxetine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Fluoxetine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Fluoxetine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Fluoxetine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Depression Image Figure 26. Global Depression Sales YoY Growth (2021-2032) & (W Units) Figure 27. Bulimia Nervosa Image Figure 28. Global Bulimia Nervosa Sales YoY Growth (2021-2032) & (W Units) Figure 29. Obsessive–Compulsive Disorder Image Figure 30. Global Obsessive–Compulsive Disorder Sales YoY Growth (2021-2032) & (W Units) Figure 31. Panic Disorder Image Figure 32. Global Panic Disorder Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Fluoxetine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Fluoxetine Market Share by Application 2025 VS 2032 Figure 37. North America Fluoxetine Sales Market Share in Volume by Application in 2025 Figure 38. North America Fluoxetine Sales Market Share in Value by Application in 2025 Figure 39. Europe Fluoxetine Sales Market Share in Volume by Application in 2025 Figure 40. Europe Fluoxetine Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Fluoxetine Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Fluoxetine Sales Market Share in Value by Application in 2025 Figure 43. Latin America Fluoxetine Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Fluoxetine Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Fluoxetine Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Fluoxetine Sales Market Share in Value by Application in 2025 Figure 47. North America Fluoxetine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Fluoxetine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Fluoxetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Fluoxetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Fluoxetine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Fluoxetine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Fluoxetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Fluoxetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Fluoxetine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Fluoxetine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Fluoxetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Fluoxetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Fluoxetine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Fluoxetine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Fluoxetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Fluoxetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Fluoxetine Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Fluoxetine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Fluoxetine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Fluoxetine Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Fluoxetine Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Fluoxetine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Oral Solution
  • Tablets
Applications
  • Depression
  • Bulimia Nervosa
  • Obsessive–Compulsive Disorder
  • Panic Disorder
  • Others
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Suzhou YUSHI Pharmaceutical
  • Sandoz
  • Mylan
  • Changzhou Siyao Pharmaceutical
  • Wockhardt
  • Torrent Pharmaceuticals
  • Pharmaceutical Associates Inc.
  • Lannett Company
  • Dr.Reddy's Laboratories
  • Aurobindo Pharma
  • Alvogen
  • Alembic Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Fluoxetine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Fluoxetine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Fluoxetine Market by Type
  6. 1.3.1 Capsules
  7. 1.3.2 Oral Solution
  8. 1.3.3 Tablets
  9. 1.4 Global Fluoxetine Market Size by Type
  10. 1.4.1 Global Fluoxetine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Fluoxetine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Fluoxetine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Fluoxetine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Fluoxetine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Fluoxetine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Fluoxetine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Fluoxetine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Fluoxetine Industry Trends
  2. 2.2 Fluoxetine Industry Drivers
  3. 2.3 Fluoxetine Industry Opportunities and Challenges
  4. 2.4 Fluoxetine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Fluoxetine Revenue (2021-2026)
  2. 3.2 Global Top Players by Fluoxetine Sales (2021-2026)
  3. 3.3 Global Top Players by Fluoxetine Price (2021-2026)
  4. 3.4 Global Fluoxetine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Fluoxetine Major Company Production Sites & Headquarters
  6. 3.6 Global Fluoxetine Company, Product Type & Application
  7. 3.7 Global Fluoxetine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Fluoxetine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Fluoxetine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Fluoxetine Tier 1, Tier 2, and Tier 3
4 Fluoxetine Regional Status and Outlook
  1. 4.1 Global Fluoxetine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Fluoxetine Historic Market Size by Region
  3. 4.2.1 Global Fluoxetine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Fluoxetine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Fluoxetine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Fluoxetine Forecasted Market Size by Region
  7. 4.3.1 Global Fluoxetine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Fluoxetine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Fluoxetine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Fluoxetine by Application
  1. 5.1 Fluoxetine Market by Application
  2. 5.1.1 Depression
  3. 5.1.2 Bulimia Nervosa
  4. 5.1.3 Obsessive–Compulsive Disorder
  5. 5.1.4 Panic Disorder
  6. 5.1.5 Others
  7. 5.2 Global Fluoxetine Market Size by Application
  8. 5.2.1 Global Fluoxetine Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Fluoxetine Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Fluoxetine Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Fluoxetine Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Fluoxetine Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Fluoxetine Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Fluoxetine Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Fluoxetine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Fluoxetine Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sun Pharmaceutical
  8. 6.2.1 Sun Pharmaceutical Company Information
  9. 6.2.2 Sun Pharmaceutical Business Overview
  10. 6.2.3 Sun Pharmaceutical Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical Fluoxetine Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Recent Developments
  13. 6.3 Suzhou YUSHI Pharmaceutical
  14. 6.3.1 Suzhou YUSHI Pharmaceutical Company Information
  15. 6.3.2 Suzhou YUSHI Pharmaceutical Business Overview
  16. 6.3.3 Suzhou YUSHI Pharmaceutical Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Suzhou YUSHI Pharmaceutical Fluoxetine Product Portfolio
  18. 6.3.5 Suzhou YUSHI Pharmaceutical Recent Developments
  19. 6.4 Sandoz
  20. 6.4.1 Sandoz Company Information
  21. 6.4.2 Sandoz Business Overview
  22. 6.4.3 Sandoz Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sandoz Fluoxetine Product Portfolio
  24. 6.4.5 Sandoz Recent Developments
  25. 6.5 Mylan
  26. 6.5.1 Mylan Company Information
  27. 6.5.2 Mylan Business Overview
  28. 6.5.3 Mylan Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan Fluoxetine Product Portfolio
  30. 6.5.5 Mylan Recent Developments
  31. 6.6 Changzhou Siyao Pharmaceutical
  32. 6.6.1 Changzhou Siyao Pharmaceutical Company Information
  33. 6.6.2 Changzhou Siyao Pharmaceutical Business Overview
  34. 6.6.3 Changzhou Siyao Pharmaceutical Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Changzhou Siyao Pharmaceutical Fluoxetine Product Portfolio
  36. 6.6.5 Changzhou Siyao Pharmaceutical Recent Developments
  37. 6.7 Wockhardt
  38. 6.7.1 Wockhardt Company Information
  39. 6.7.2 Wockhardt Business Overview
  40. 6.7.3 Wockhardt Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Wockhardt Fluoxetine Product Portfolio
  42. 6.7.5 Wockhardt Recent Developments
  43. 6.8 Torrent Pharmaceuticals
  44. 6.8.1 Torrent Pharmaceuticals Company Information
  45. 6.8.2 Torrent Pharmaceuticals Business Overview
  46. 6.8.3 Torrent Pharmaceuticals Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Torrent Pharmaceuticals Fluoxetine Product Portfolio
  48. 6.8.5 Torrent Pharmaceuticals Recent Developments
  49. 6.9 Pharmaceutical Associates Inc.
  50. 6.9.1 Pharmaceutical Associates Inc. Company Information
  51. 6.9.2 Pharmaceutical Associates Inc. Business Overview
  52. 6.9.3 Pharmaceutical Associates Inc. Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pharmaceutical Associates Inc. Fluoxetine Product Portfolio
  54. 6.9.5 Pharmaceutical Associates Inc. Recent Developments
  55. 6.10 Lannett Company
  56. 6.10.1 Lannett Company Company Information
  57. 6.10.2 Lannett Company Business Overview
  58. 6.10.3 Lannett Company Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Lannett Company Fluoxetine Product Portfolio
  60. 6.10.5 Lannett Company Recent Developments
  61. 6.11 Dr.Reddy's Laboratories
  62. 6.11.1 Dr.Reddy's Laboratories Company Information
  63. 6.11.2 Dr.Reddy's Laboratories Business Overview
  64. 6.11.3 Dr.Reddy's Laboratories Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Dr.Reddy's Laboratories Fluoxetine Product Portfolio
  66. 6.11.5 Dr.Reddy's Laboratories Recent Developments
  67. 6.12 Aurobindo Pharma
  68. 6.12.1 Aurobindo Pharma Company Information
  69. 6.12.2 Aurobindo Pharma Business Overview
  70. 6.12.3 Aurobindo Pharma Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Aurobindo Pharma Fluoxetine Product Portfolio
  72. 6.12.5 Aurobindo Pharma Recent Developments
  73. 6.13 Alvogen
  74. 6.13.1 Alvogen Company Information
  75. 6.13.2 Alvogen Business Overview
  76. 6.13.3 Alvogen Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Alvogen Fluoxetine Product Portfolio
  78. 6.13.5 Alvogen Recent Developments
  79. 6.14 Alembic Pharmaceuticals
  80. 6.14.1 Alembic Pharmaceuticals Company Information
  81. 6.14.2 Alembic Pharmaceuticals Business Overview
  82. 6.14.3 Alembic Pharmaceuticals Fluoxetine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Alembic Pharmaceuticals Fluoxetine Product Portfolio
  84. 6.14.5 Alembic Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Fluoxetine Sales by Country
  2. 7.1.1 North America Fluoxetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Fluoxetine Sales by Country (2021-2026)
  4. 7.1.3 North America Fluoxetine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Fluoxetine Market Size by Country
  6. 7.2.1 North America Fluoxetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Fluoxetine Market Size by Country (2021-2026)
  8. 7.2.3 North America Fluoxetine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Fluoxetine Sales by Country
  2. 8.1.1 Europe Fluoxetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Fluoxetine Sales by Country (2021-2026)
  4. 8.1.3 Europe Fluoxetine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Fluoxetine Market Size by Country
  6. 8.2.1 Europe Fluoxetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Fluoxetine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Fluoxetine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Fluoxetine Sales by Country
  2. 9.1.1 Asia-Pacific Fluoxetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Fluoxetine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Fluoxetine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Fluoxetine Market Size by Country
  6. 9.2.1 Asia-Pacific Fluoxetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Fluoxetine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Fluoxetine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Fluoxetine Sales by Country
  2. 10.1.1 South America Fluoxetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Fluoxetine Sales by Country (2021-2026)
  4. 10.1.3 South America Fluoxetine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Fluoxetine Market Size by Country
  6. 10.2.1 South America Fluoxetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Fluoxetine Market Size by Country (2021-2026)
  8. 10.2.3 South America Fluoxetine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Fluoxetine Sales by Country
  2. 11.1.1 Middle East and Africa Fluoxetine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Fluoxetine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Fluoxetine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Fluoxetine Market Size by Country
  6. 11.2.1 Middle East and Africa Fluoxetine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Fluoxetine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Fluoxetine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Fluoxetine Value Chain Analysis
  2. 12.1.1 Fluoxetine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Fluoxetine Production Mode & Process
  7. 12.2 Fluoxetine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Fluoxetine Distributors
  10. 12.2.3 Fluoxetine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst